Purpose
to test the stability of the Institut Pasteur-quadrivalent Shigella vaccine (IP-QSV), a promising quadrivalent candidate vaccine developed to prevent shigellosis in children from low- and middle-income countries
Grantee
Division
Global Health
Date
NOVEMBER 2024
Region served
GLOBAL
Committed amount
$1,147,089
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
49
Grantee location
Paris, France
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.